Vimseltinib Side Effects
Applies to vimseltinib: oral capsules.
Side effects include:
Most common adverse effects (≥20%): Increased AST concentrations, increased ALT concentrations, periorbital edema, fatigue, rash, increased cholesterol, peripheral edema, facial edema, decreased neutrophils, decreased leukocytes, pruritus.
For healthcare professionals
Applies to vimseltinib: oral capsule.
General adverse events
The most common adverse reactions included increased AST, periorbital edema, fatigue, rash, increased cholesterol, peripheral edema, face edema, decreased neutrophils, decreased leukocytes, pruritus, and increased ALT.[Ref]
Cardiovascular
- Very common (10% or more): Hypertension (up to 17%)
Dermatologic
- Very common (10% or more): Rash (up to 47%), pruritus (up to 29%)
- Common (1% to 10%): Subcutaneous abscess, cellulitis
Hematologic
- Very common (10% or more): Decreased neutrophils (up to 31%), decreased leukocytes (up to 29%)
Hepatic
- Very common (10% or more): Increased AST (up to 92%), increased ALT (up to 24%)
During clinical trials, grade 3 increases in AST and ALT were reported in 2% and 1% of patients, respectively. Dose interruptions and reductions due to increased AST/ALT occurred in 2% and 1% of patients, respectively; at least 1 patient discontinued therapy due to grade 3 increased AST.
Musculoskeletal
- Common (1% to 10%): Increased creatine phosphokinase
Nervous system
- Very common (10% or more): Neuropathy (up to 12%)
Ocular
- Very common (10% or more): Periorbital edema (up to 60%), increased lacrimation (up to 12%), dry eye (up to 10%)
- Common (1% to 10%): Blurred vision
Other
- Very common (10% or more): Fatigue (up to 59%), increased cholesterol (up to 43%), peripheral edema (up to 33%), face edema (up to 31%), increased alkaline phosphatase (up to 14%), increased magnesium (up to 13%), decreased calcium (up to 13%)
Renal
- Very common (10% or more): Increased creatinine (up to 17%)
See also:
References
1. (2025) "Product Information. Romvimza (vimseltinib)." Deciphera Pharmaceuticals
More about vimseltinib
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Vimseltinib side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.